Hikma Pharmaceuticals PLC (HIK) — Cash Flow Reinvestment Rate
Hikma Pharmaceuticals PLC (HIK) has a Cash Flow Reinvestment Rate of 0.42x as of June 2025, reinvesting GBX68.00 Million (capex GBX68.00 Million ) from operating cash flow of GBX161.00 Million. See Hikma Pharmaceuticals PLC free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hikma Pharmaceuticals PLC Cash Flow Reinvestment Rate (2002–2024)
Historical reinvestment intensity for Hikma Pharmaceuticals PLC across 23 annual periods. For the full cash flow conversion analysis, see Hikma Pharmaceuticals PLC (HIK) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Hikma Pharmaceuticals PLC (2002–2024)
Year-by-year capital reinvestment analysis for Hikma Pharmaceuticals PLC. See Hikma Pharmaceuticals PLC free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.97x | GBX546.00 Million | GBX564.00 Million | GBX165.00 Million | ▲ +17.3% |
| 2023 | 0.83x | GBX502.00 Million | GBX608.00 Million | GBX169.00 Million | ▼ -47.4% |
| 2022 | 1.57x | GBX832.00 Million | GBX530.00 Million | GBX225.00 Million | ▲ +114.5% |
| 2021 | 0.73x | GBX467.00 Million | GBX638.00 Million | GBX229.00 Million | ▲ +49.6% |
| 2020 | 0.49x | GBX227.00 Million | GBX464.00 Million | GBX224.00 Million | ▲ +19.0% |
| 2019 | 0.41x | GBX194.00 Million | GBX472.00 Million | GBX186.00 Million | ▲ +59.2% |
| 2018 | 0.26x | GBX111.00 Million | GBX430.00 Million | GBX107.00 Million | ▼ -0.6% |
| 2017 | 0.26x | GBX115.00 Million | GBX443.00 Million | GBX107.00 Million | ▼ -90.7% |
| 2016 | 2.79x | GBX817.00 Million | GBX293.00 Million | GBX122.00 Million | ▲ +890.8% |
| 2015 | 0.28x | GBX103.00 Million | GBX366.00 Million | GBX82.00 Million | ▲ +6.8% |
| 2014 | 0.26x | GBX112.00 Million | GBX425.00 Million | GBX91.00 Million | ▲ +5.7% |
| 2013 | 0.25x | GBX84.00 Million | GBX337.00 Million | GBX59.00 Million | ▼ -49.7% |
| 2012 | 0.50x | GBX90.19 Million | GBX182.16 Million | GBX90.19 Million | ▼ -34.8% |
| 2011 | 0.76x | GBX78.00 Million | GBX102.64 Million | GBX78.00 Million | ▲ +98.3% |
| 2010 | 0.38x | GBX53.20 Million | GBX138.79 Million | GBX53.20 Million | ▲ +0.2% |
| 2009 | 0.38x | GBX40.38 Million | GBX105.52 Million | GBX40.38 Million | ▼ -66.2% |
| 2008 | 1.13x | GBX65.52 Million | GBX57.87 Million | GBX65.52 Million | ▼ -11.2% |
| 2007 | 1.28x | GBX54.99 Million | GBX43.12 Million | GBX54.99 Million | ▼ -27.1% |
| 2006 | 1.75x | GBX52.44 Million | GBX29.99 Million | GBX52.44 Million | ▲ +138.5% |
| 2005 | 0.73x | GBX23.98 Million | GBX32.71 Million | GBX23.98 Million | ▲ +12.9% |
| 2004 | 0.65x | GBX21.33 Million | GBX32.84 Million | GBX21.33 Million | — |
| 2003 | 0.00x | GBX0.00 | GBX18.35 Million | GBX0.00 | — |
| 2002 | 0.00x | GBX0.00 | GBX14.35 Million | GBX0.00 | — |